ESPE Yearbook of Paediatric Endocrinology

ESPE Yearbook of Paediatric Endocrinology

ISSN 1662-4009 (online)

Published by BioScientifica

Page 1 of about 1 results

ey0016.12-5 | Type 2 Diabetes | ESPEYB16

12.5. Liraglutide in children and adolescents with type 2 diabetes

WV Tamborlane , M Barrientos-Perez , U Fainberg , H Frimer-Larsen , M Hafez , PM Hale , MY Jalaludin , M Kovarenko , I Libman , JL Lynch , P Rao , N Shehadeh , S Turan , D Weghuber , T Barrett , I Ellipse Trial

N Engl J Med 2019; 10.1056/NEJMoa1903822.DOI: 10.1056/NEJMoa1903822http://www.ncbi.nlm.nih.gov/pubmed/31034184Summary: In a double-blind, randomized, phase 3 trial, 135 overweight and obese adolescents, aged 10 to 17 years with T2DM, were randomly assigned to receive subcutaneous liraglutide (up to 1.8 mg per day) or placebo, bot...
0 shares

Published by BioScientifica

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more